Skip to main content

Swine Flu Update

On 5 May 2009, I arrived at my south London general practice to discover that I was at the "epicentre" of the H1N1 outbreak in the UK. Two local schools had been closed because of diagnosed cases of swine flu among their pupils. However, by the time the new cases of swine flu had come to light, many people would have been exposed, some of them developing subclinical infection or minor symptoms and not seeking medical advice. Closing the schools may therefore not limit the spread of the H1N1 virus because exposed and potentially infected people are still carrying out normal social activities. Subsequent research from some of my colleagues at Imperial College suggests that school closure may be beneficial in flu outbreaks. I am more cautious about applying this evidence from areas very far from central London.

My local health protection unit was unable to screen people with symptoms who had been in contact with swine flu cases. General practitioners were instead asked to do this at patients’ homes. The more logical solution would have been for the health protection unit to have established centralised testing and treatment centres to ensure that suspected cases were investigated promptly by trained staff and prophylactic treatment given if indicated. This is something that should be looked at because trying to combine routine clinical services whilst at the same time dealing with contact tracing is very difficult and disruptive.

The experience in my 10,000 patient practice in a place where many people would have been exposed to swine flu cases showed no evidence of widespread dissemination of the H1N1 virus in the early phase of the outbreak. The number of people presenting with symptoms of influenza or other viral illnesses remained low and at the expected rate in early summer. There was then a marked increase in June 2009 but consultations for viral infections then fell substantially in July and August. The cases that have presented to the practice have all generally been mild and recovered quickly. If this pattern is repeated elsewhere, the eventual number of deaths and complications from swine flu may be substantially less than that predicted by some of the more pessimistic commentators.

I am concerned about the widespread use of Tamiflu (Oseltamivir). By using antiviral drugs so liberally — for what is currently a mild form of flu — we risk generating resistance so that when a more virulent form of flu presents the drugs may no longer be effective. Moreover, in areas where testing is still going on, as few as 10-20% of suspected cases have confirmed H1N1 infection, meaning that many patients who receive Tamiflu don't actually have swine flu. The current policy may therefore have very limited benefits, even without taking into account the enormous resource implications, the important work left undone as general practitioners and others focus their efforts on swine flu, and the loss of staff goodwill. I question the need to continue the use of antiviral drugs for people who are not in at risk groups.

Report from the UK "epicentre"

Policy on antiviral drugs needs to be revised


Popular posts from this blog

Can GPs issue private prescriptions to NHS patients?

The NHS prescription charge in England is currently £8.60 per item. At this level, many commonly prescribed drugs will cost less than the prescription charge and so some NHS patients may occasionally ask if they can have a private prescription rather than an NHS prescription.

In the past, some GPs have been advised that they could issue both an NHS FP10 and a private prescription, and let the patient decide which to use. But the British Medical Association's General Practice Committee has obtained legal advice that said under the current primary care contract, GPs in England may not issue a private prescription alongside or as an alternative to an NHS FP10 prescription. In any consultation where a GP needs to issue an FP10, the concurrent issue of a private prescription would be a breach of NHS regulations.

The issuing of a private prescription in such circumstances could also be seen as an attempt to deprive the NHS of the funds it would receive from the prescription charge. Fur…

What will Brexit mean for the NHS?

On the 29 March 2017, the Prime Minister of the UK Theresa May, formally notified the European Union (EU) Council President, Donald Tusk, of the UK’s intention to leave the EU. Theresa May’s letter to Donald Tusk triggers a two-year process during which the UK will have to negotiate both the terms of its exit from EU and the arrangements that will replace those we have had for over 40 years with the other member states of the EU. The consequences of the United Kingdom’s departure from the EU (commonly referred to as ‘Brexit’) will be wide-ranging and will affect all areas of UK’s society, including the National Health Service (NHS).

For the NHS, Brexit comes at a time when it faces many other major challenges. These include severe financial pressures, rising workload, increased waiting times for both primary care and specialist services, and shortages of health professionals in many key areas (such as in general practice and in emergency departments). The NHS also faces challenges fr…

Dr Demis Hassabis, Co-Founder and CEO of DeepMind, Speaks about AI in Healthcare

On 28 September 2017, I attended the Annual Institute of Global Health Innovation Lecture: Artificial General Intelligence and Healthcare, delivered by Dr Demis Hassabis, co-founder and CEO of Google DeepMind. Artificial intelligence is the science of making machines smart argued Dr Hassabis, so how can we make it improve the healthcare sector? Dr Hassabis then went on to describe the work that DeepMind was carrying out in healthcare in areas such as organising information, deep learning to support the reporting of medical images (such as scans and pathology slides), and biomedical science. Dr Hassabis also discussed the challenges of applying techniques such as reinforcement learning in healthcare. He concluded that artificial intelligence has great scope for improving healthcare; for example, by prioritising the tasks that clinicians had to carry out and by providing decision support aids for both patients and doctors. Dr Hassabis also discussed some of the ethical issues in using …